SpeechATAXIA- a multinational, multilanguage consortia for speech in hereditary ataxias – powered by Redenlab

Redenlab is supporting a new speech focussed consortium for ataxia. SpeechATAXIA is a multi-language, multi-national, multi-ataxia study measuring communication change. Participants are recruited from investigator sites in Australia, New Zealand, Europe, North and South America.

The consortia goals include:
Precisely describe longitudinal changes occurring in speech as disease progresses,
– Identify predictors of progression and discover if critical milestones exist in the disease course,
– Explore how communication decline shapes quality of life and disease management,
– Strengthen genotype-phenotype associations to create disease specific profiles.

The program of research is supported by the Ataxia Global Initiative.

Related Post

  • Posted on 25 January, 2024
    MEDIA RELEASE Melbourne, 19 January 2024 — Redenlab, a leader in innovative healthcare solutions, ispleased to announce a groundbreaking study...
    • Posted on 24 October, 2023
      Friedreich ataxia (FA) is a progressive, genetically inherited multisystem disease that affects children and adults. FA leads to significant changes...
      • Posted on 24 October, 2023
        Friedreich ataxia (FA) is an inherited, multisystem neurodegenerative disease that results in profound changes to speech, swallowing, balance, walking, cardiac...